Li Hong-qiang, Zhang Lei, Zhao Hui, Ji Lin-xiang, Yang Ren-chi
Department of Thrombosis and Hemostasis, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Chin Med J (Engl). 2005 Jan 5;118(1):34-7.
Adult chronic idiopathic thrombocytopenic purpura (ITP) is a common hematologic disease characterized by persistent thrombocytopenia. So far, there were only a few reports on adult Chinese patients with chronic ITP. This study aimed at defining the treatment outcome and prognostic factors for chronic ITP based on a large cohort of Chinese patients followed up for over 25 years at a single center.
The medical records of 1791 patients aged 14 years or older who were diagnosed as having chronic ITP at our hospital from 1974 to 1999 were retrospectively analyzed.
The female-to-male ratio was 2:1, with a median age of 34 years (ranging from 14 to 80 years), median platelet count of 38 x 10(9)/L [range (1-99) x 10(9)/L], and median follow-up of 36 months (range 1-220 months). Steroids were used in 689 patients, among them 209 (30.3%) achieved complete remission (CR). A splenectomy was performed in 124 patients, and response to steroid pre-splenectomy was not available in 14 patients. The CR rate after a splenectomy was lower in steroid nonresponders (29 of 90, 32.2%) than in those who relapsed after successful steroid treatment (12 of 20, 60.0%) (P < 0.05). In comparison with patients negative for antinuclear antibody (ANA), those who were ANA positive had similar responses to steroids, but a significantly shorter remission period after a splenectomy (P < 0.01).
Adult Chinese chronic ITP patients can have long-term remission after steroid therapy and splenectomies. Primary steroid refractoriness is a prognostic factor predicting poor subsequent response to a splenectomy.
成人慢性特发性血小板减少性紫癜(ITP)是一种以持续性血小板减少为特征的常见血液系统疾病。到目前为止,关于成年中国慢性ITP患者的报道较少。本研究旨在基于在单一中心随访超过25年的大量中国患者队列,确定慢性ITP的治疗结果和预后因素。
回顾性分析了1974年至1999年在我院诊断为慢性ITP的1791例14岁及以上患者的病历。
男女比例为2:1,中位年龄为34岁(范围为14至80岁),中位血小板计数为38×10⁹/L[范围(1 - 99)×10⁹/L],中位随访时间为36个月(范围1至220个月)。689例患者使用了类固醇,其中209例(30.3%)实现完全缓解(CR)。124例患者接受了脾切除术,14例患者术前未使用类固醇。类固醇治疗无效者脾切除术后的CR率(90例中的29例,32.2%)低于类固醇治疗成功后复发者(20例中的12例,60.0%)(P < 0.05)。与抗核抗体(ANA)阴性患者相比,ANA阳性患者对类固醇的反应相似,但脾切除术后缓解期明显缩短(P < 0.01)。
成年中国慢性ITP患者在接受类固醇治疗和脾切除术后可实现长期缓解。原发性类固醇难治性是预测脾切除术后后续反应不佳的预后因素。